vimarsana.com

Page 7 - ஜப்பான் பெருநிறுவன செய்தி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DigiMax Expands Global Marketing into Asia with Signing of Collaboration Deal in Hong Kong

DigiMax Expands Global Marketing into Asia with Signing of Collaboration Deal in Hong Kong
jcnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jcnnewswire.com Daily Mail and Mail on Sunday newspapers.

Showa Denko Installs Additional Lines to Produce Aluminum Heat Radiators for xEVs

Showa Denko Installs Additional Lines to Produce Aluminum Heat Radiators for xEVs TOKYO, Jul 29, 2021 - (JCN Newswire) - Showa Denko K.K. (SDK; TSE:4004) decided to double Oyama Plant s capacity to produce aluminum heat radiators for power modules (PMs)[1] to be installed in electrified vehicles (xEVs) including battery electric vehicles, hybrid vehicles and plug-in hybrid vehicles, in order to respond to an increase in demand for aluminum heat radiators for PMs. SDK has started installation of the additional production line whose start-up of operation is scheduled to be at the beginning of 2022. Aluminum heat radiator for PM PMs are important parts of xEVs and contribute to the improvement in the performance of xEVs. For example, PMs contribute to extension of cruising range and improvement in fuel economy of cars. PMs are usually installed into limited spaces of xEVs. Therefore, heat radiators for PMs must be small, be designed to allow various installation methods, and have hi

Biogen and Eisai Announce ADUHELM (aducanumab-avwa) Data Presentations at Alzheimer s Association International Conference 2021

Biogen and Eisai Announce ADUHELM (aducanumab-avwa) Data Presentations at Alzheimer s Association International Conference 2021 - Item-level analysis from EMERGE trial shows consistency in slowing decline across cognitive, functional and behavioral measures in early Alzheimer s disease - Presentations include an assessment of the correlation between reductions in amyloid beta and other biomarkers of Alzheimer s disease and clinical decline after treatment with ADUHELM - Presentation on ARIA data from Phase 3 trials provides insights for effective monitoring and management in real-world clinical practice TOKYO, Jul 27, 2021 - (JCN Newswire) - Biogen (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo, Japan) today announced that Biogen, as part of its Alzheimer s disease (AD) research portfolio, will contribute four virtual posters that showcase data from its clinical trials with ADUHELM (aducanumab-avwa) injection 100 mg/mL solution at the Alzheimer s Association International Conference

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.